Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
1 other identifier
interventional
108
1 country
1
Brief Summary
This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method. 120 adults were divided into 3 groups.
- 1.Control group: receive placebo treatment, once a day, four pills each time.
- 2.Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 582 mg.
- 3.Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1164 mg.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2021
CompletedStudy Start
First participant enrolled
September 16, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 4, 2026
February 1, 2026
4.4 years
August 27, 2021
February 2, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each aspect has a minimum score of 0 and a maximum of 3 points. The total score range is 0-21 points. When the PSQI score is greater than 5 points, it indicates that there is a sleep quality disorder. The higher the score, the worse the sleep quality.
3 month
Tinnitus Handicap Inventory
The Tinnitus Handicap Inventory (THI) comprises 25 items grouped into three subscales: Functional, Emotional, and Catastrophic. The Functional subscale (11 items) deals with limitations caused by tinnitus in the areas of mental, social, and physical functioning. The Emotional subscale (9 items) concerns affective responses to tinnitus, e.g. anger, frustration, depression, anxiety. The Catastrophic subscale (5 items) probes the most severe reactions to tinnitus, such as loss of control, inability to escape from tinnitus, and fear of having a terrible disease. For each item a patient can respond with a "yes" (scored 4 points), "sometimes" (2 points), or "no" (0 points). The responses are summed within each subscale and for the total scale. The higher the score, the greater the perceived tinnitus severity.
3 month
Study Arms (3)
Control
PLACEBO COMPARATORreceive placebo treatment, once a day, four pills each time.
Herbal compound low-dose
EXPERIMENTALonce a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 582 mg.
Herbal compound high-dose
EXPERIMENTALonce a day, four capsules each time. The total amount of herbal compound capsules is 1164 mg.
Interventions
The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.
The total amount of herbal compound capsules is 582 mg.
The total amount of herbal compound capsules is 1164 mg.
Eligibility Criteria
You may qualify if:
- Age 20\~70 years old
- Non-dialysis patients
- Suffering from sleep disorders and tinnitus
- Refuse to take sleeping pills
You may not qualify if:
- Patients who are bedridden or unable to take care of themselves.
- dialysis patients.
- Patients who cannot understand the details of this study or cannot cooperate with the examination.
- History of alcohol or drug abuse.
- Pregnant and lactating women
- Patients with moderate to severe sleep apnea
- Take sleeping pills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Chiayi City, 66247, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Juen-Haur Hwang, MD, PhD.
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2021
First Posted
January 28, 2022
Study Start
September 16, 2021
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02